RxDoctor Payments Data

Zubeda Rajput

Internal Medicine · Pleasantville, NJNPI 1790746725

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 173 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AstraZeneca at 28.1% of the total. Reporting peaked in 2019 at $788 and has fallen 81.6% since, to $145 in 2023.

$2,470in general payments, 2019–2025

Across 173 payments — averaging $14.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$693
  • Amarin Pharma, Inc.$304
  • Novo Nordisk$276
  • GSK$195
  • Kowa Pharmaceuticals America, Inc.$181
  • Lilly USA, LLC$167
  • plus $654 from 15 others

What the payments were for

  • Food & beverage$2,470100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,470 in reported general payments places this provider in the 80th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey →

Other internal medicine in Pleasantville

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →